BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6994989)

  • 21. The effects of general anesthesia on the central nervous and cardiovascular system toxicity of local anesthetics.
    Copeland SE; Ladd LA; Gu XQ; Mather LE
    Anesth Analg; 2008 May; 106(5):1429-39, table of contents. PubMed ID: 18420857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of efficacy and tolerance of oral mexiletine by intravenous lidocaine application.
    Zehender M; Geibel A; Treese N; Hohnloser S; Meinertz T; Just H
    Clin Pharmacol Ther; 1988 Oct; 44(4):389-95. PubMed ID: 3168391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lidocaine blood levels in patients with acute myocardial infarction.
    Pickering JE
    Pa Med; 1973 Mar; 76(3):57-9. PubMed ID: 4688984
    [No Abstract]   [Full Text] [Related]  

  • 24. Computer-assisted individualized lidocaine dosage: clinical evaluation and comparison with physician performance.
    Vozeh S; Uematsu T; Ritz R; Schmidlin O; Kaufman G; Scholer A; Follath F
    Am Heart J; 1987 Apr; 113(4):928-33. PubMed ID: 3565242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention, clinical aspects and therapy of the side-effects of lidocaine].
    Kettner W; Lenz M; Kettner E; Banditt P; Walther H
    Z Gesamte Inn Med; 1984 Oct; 39(20):501-5. PubMed ID: 6516492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical guidelines for the use of lidocaine. Prevention and treatment of cardiac arrhythmias.
    Harrison DC
    JAMA; 1975 Sep; 233(11):1202-4. PubMed ID: 1174178
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimal lidocaine dosing in patients with myocardial infarction.
    Lopez LM; Mehta JL; Robinson JD; Roberts RJ
    Ther Drug Monit; 1982; 4(3):271-6. PubMed ID: 6753254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic based adjustment of lidocaine antiarrhythmic schedule.
    Voicu V; Mircioiu C; Jinga M; Ionescu M; Burcea X; Ionescu DD; Lupescu G
    Eur J Drug Metab Pharmacokinet; 1994; 19(1):33-6. PubMed ID: 7957449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lidocaine in the treatment of arrhythmia in acute myocardial infarct].
    Dunning AJ; Kettner H; Wesdorp JC
    Ned Tijdschr Geneeskd; 1969 Dec; 113(52):2319-24. PubMed ID: 5362041
    [No Abstract]   [Full Text] [Related]  

  • 30. The measurement of lignocaine at low concentrations in plasma, a comparison of gas liquid chromatography with enzyme immunoassay.
    Jain S; Johnston A
    Br J Clin Pharmacol; 1979 Dec; 8(6):598-9. PubMed ID: 391259
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative studies on dose adjustment of intraoperative lidocaine therapy in heart failure patients].
    Biscoping J; Kling D; von Bormann B; Hehrlein F; Hempelmann G
    Anasth Intensivther Notfallmed; 1985 Jun; 20(3):136-8. PubMed ID: 4037261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized double-blind study of intravenous tocainide versus lidocaine for suppression of ventricular arrhythmias after cardiac surgery.
    Manolis AS; Smith E; Payne D; Rastegar H; Cleveland R; Estes NA
    Clin Cardiol; 1990 Mar; 13(3):177-81. PubMed ID: 2108835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative CNS toxicity of lidocaine, etidocaine, bupivacaine, and tetracaine in awake dogs following rapid intravenous administration.
    Liu PL; Feldman HS; Giasi R; Patterson MK; Covino BG
    Anesth Analg; 1983 Apr; 62(4):375-9. PubMed ID: 6829942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current understanding of lidocaine as an antiarrhythmic agent: a review.
    Anderson JL
    Clin Ther; 1984; 6(2):125-41. PubMed ID: 6200230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias].
    Rolli A; Bonatti V; Finardi A; Favaro L; Botti G
    G Ital Cardiol; 1981; 11(4):468-76. PubMed ID: 6169578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacology and clinical use of lidocaine as an antiarrhythmic drug--1972.
    Harrison DC; Alderman EL
    Mod Treat; 1972 Feb; 9(1):139-75. PubMed ID: 4555217
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparative evaluation of the effects of propafenone and lidocaine on early ventricular arrhythmias after acute myocardial infarction.
    Touboul P; Moleur P; Mathieu MP; Vrancea F; Ferry S; Kirkorian G; Atallah G; Marchand A; Stahl C; Zoheir F
    Eur Heart J; 1988 Nov; 9(11):1188-93. PubMed ID: 3234410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Slower lidocaine elimination and dose adjustment in patients with heart failure].
    Follath F; Ritz R; Vozeh S; Wenk M
    Schweiz Med Wochenschr; 1982 May; 112(22):789-91. PubMed ID: 6808662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic approach to the clinical use of lidocaine intravenously.
    Greenblatt DJ; Bolognini V; Koch-Weser J; Harmatz JS
    JAMA; 1976 Jul; 236(3):273-7. PubMed ID: 947029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of lidocaine in the treatment of ventricular arrhythmias].
    Antonini FM; Fumagalli C; Bertini G; Ricci F
    Cardiol Prat; 1970 Jun; 21(3):141-54. PubMed ID: 5511551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.